Anticancer Research 2013-09-01

Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.

Huynh Cao, Kenneth Yamamoto, Li-Xi Yang, Robert Weber

Index: Anticancer Res. 33(9) , 3879-85, (2013)

Full Text: HTML

Abstract

Hodgkin lymphoma (HL) is characterized by malignant Reed-Sternberg cells which express CD30. Current National Comprehensive Cancer Network guidelines for patients with advanced HL (stage III/IV disease) recommend adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD), or escalated bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) as first-line regimens. ABVD appears to be as effective, with fewer side effects, as escalated BEACOPP. Escalated BEACOPP leads to a greater progression-free survival but no difference in overall survival. Recent advancements in technology have enabled an exciting shift to molecular-targeted cancer therapy. Brentuximab vedotin, a CD30-directed antibody conjugate, specifically targets malignant HL cells. It is approved by the Food and Drug Administration for the treatment of systemic anaplastic large-cell lymphoma and refractory HL that has progressed after autologous stem cell transplant, or after two prior multiagent chemotherapy regimens among patients ineligible to receive a transplant.


Related Compounds

  • Vincristine Sulfa...
  • Bleomycin sulfate

Related Articles:

Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.

2014-12-01

[Eur. J. Cancer 50(18) , 3243-61, (2014)]

OCT4 mutations in human erythroleukemic cells: implications for multiple drug resistance (MDR) phenotype.

2015-02-01

[Mol. Cell Biochem. 400(1-2) , 41-50, (2015)]

Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.

2014-12-01

[Biochim. Biophys. Acta 1841(12) , 1672-82, (2015)]

Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids.

2015-02-01

[Fundam. Clin. Pharmacol. 29(1) , 62-71, (2015)]

Effects of regular consumption of vitamin C-rich or polyphenol-rich apple juice on cardiometabolic markers in healthy adults: a randomized crossover trial.

2014-12-01

[Eur. J. Nutr. 53(8) , 1645-57, (2014)]

More Articles...